Advertisement
Home Blog Page 1783
From 1997 to 2014

Prevalence of Severe Maternal Morbidity Increased Across Groups

Racial and ethnic disparities in severe maternal morbidity have remained persistent over time
Three factors predict clinically significant neuropsychiatric adverse events in smokers with or without mental health conditions who use cessation pharmacotherapy

Three Factors Predict Psych Events With Drugs for Smoking Cessation

Anxiety, history of suicidal ideation/behavior, being white associated with higher risk for events
Blood donation is associated with iron deficiency among both adolescent girls and younger adult women in the United States

Younger Female Blood Donors Vulnerable to Iron Deficiency

In teens and women younger than 50, absent iron stores and anemia more common in blood donors
Monsanto's Roundup weedkiller was a major factor in a California man's cancer

Jury Finds Roundup a Major Contributor to Man’s Cancer

Landmark verdict could impact hundreds of other similar lawsuits
Questions about breast implant safety are getting new attention from the U.S. Food and Drug Administration as thousands of women say their implants cause debilitating joint pain and fatigue.

FDA Takes New Look at Breast Implant Safety

Agency has acknowledged that breast implants may contain materials that affect people's health
A pregnancy-adapted algorithm can safely avoid diagnostic imaging in a proportion of pregnant women with suspected pulmonary embolism

Pregnancy-Adapted Algorithm Avoids Diagnostic Imaging for PE

Suspected pulmonary embolism safely ruled out in some pregnant women with diagnostic algorithm
Antiepileptic drug use is not significantly associated with dementia risk in patients in Germany

Antiepileptic Drugs Not Tied to Dementia Risk

No increased overall risk found, but levetiracetam generic brands tied to higher dementia risk
Compared with chemotherapy alone

Trastuzumab Tied to Higher Long-Term Risk for Heart Failure

Increased risk for heart failure seen in breast cancer survivors given trastuzumab rather than chemo alone
Zulresso (brexanolone) injection has been approved for intravenous use in the treatment of postpartum depression in adult women

FDA: First Treatment Approved Specifically for Postpartum Depression

Zulresso administered by IV infusion over 60-hour period; patients must be monitored during infusion
Cannabis use is associated with increased odds of psychotic disorder

Daily Cannabis Use May Up Risk for Developing Psychotic Disorder

Daily cannabis use, especially high-potency types, linked to increased odds of psychotic disorder